Home/Filings/4/0001209191-12-034920
4//SEC Filing

STEINMETZ MICHAEL 4

Accession 0001209191-12-034920

CIK 0001339455other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 4:46 PM ET

Size

14.3 KB

Accession

0001209191-12-034920

Insider Transaction Report

Form 4
Period: 2012-06-19
Transactions
  • Sale

    Common Stock

    2012-06-19$0.29/sh12,000$3,4803,759,735 total(indirect: See Footnote)
Transactions
  • Sale

    Common Stock

    2012-06-19$0.29/sh12,000$3,4803,759,735 total(indirect: See Footnote)
Transactions
  • Sale

    Common Stock

    2012-06-19$0.29/sh12,000$3,4803,759,735 total(indirect: See Footnote)
WHEELER KURT
Director
Transactions
  • Sale

    Common Stock

    2012-06-19$0.29/sh12,000$3,4803,759,735 total(indirect: See Footnote)
EVNIN LUKE
10% Owner
Transactions
  • Sale

    Common Stock

    2012-06-19$0.29/sh12,000$3,4803,759,735 total(indirect: See Footnote)
HENNER DENNIS
10% Owner
Transactions
  • Sale

    Common Stock

    2012-06-19$0.29/sh12,000$3,4803,759,735 total(indirect: See Footnote)
Transactions
  • Sale

    Common Stock

    2012-06-19$0.29/sh12,000$3,4803,759,735 total(indirect: See Footnote)
Footnotes (2)
  • [F1]The shares were sold as follows: 10,003 by MPM BioVentures III-QP, L.P. ("BV III QP"), 673 by MPM BioVentures III, L.P. ("BV III"), 177 by MPM Asset Management Investors 2005 BVIII LLC ("AM 2005"), 302 by MPM BioVentures III Parallel Fund, L.P. ("BV Parallel") and 845 by MPM BioVentures III GmbH & Co. Beteiligungs KG ("BV KG"). MPM BioVentures III GP, L.P. ("MPM III GP") and MPM BioVentures III LLC ("MPM III LLC") are the direct and indirect general partners of BV III QP, BV III, BV Parallel and BV KG. Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Nicholas Simon III, Michael Steinmetz and Kurt Wheeler are the Series A members of MPM III LLC and the managers of AM 2005.
  • [F2]The shares are held as follows: 3,142,318 by BV III QP, 211,293 by BV III, 55,665 by AM 2005, 94,920 by BV Parallel and 265,539 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.

Issuer

Somaxon Pharmaceuticals, Inc.

CIK 0001339455

Entity typeother

Related Parties

1
  • filerCIK 0001166285

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:46 PM ET
Size
14.3 KB